Status:
WITHDRAWN
Cloud-Based Mapping for Personalized Ablation
Lead Sponsor:
Stanford University
Conditions:
Atrial Fibrillation
Arrhythmias, Cardiac
Eligibility:
All Genders
21-80 years
Brief Summary
Atrial fibrillation is a serious public health issue that affects over 5 million Americans in whom it may cause skipped beats, dizziness, stroke and even death. This study seeks to improve our underst...
Detailed Description
This project will focus on the development of a novel paradigm for electrophysiologic data analysis and interpretation using cloud-based computing resources and mobile technology. Currently, electroph...
Eligibility Criteria
Inclusion
- men and women of any ethnicity
- aged 21-80 years
- undergoing ablation of atrial fibrillation at Stanford University
- failed or be intolerant of ≥ 1 anti-arrhythmic drug or not willing to accept antiarrhythmic drug therapy.
Exclusion
- active coronary ischemia or decompensated heart failure
- atrial or ventricular clot on trans-esophageal echocardiography
- pregnancy (to minimize fluoroscopic exposure)
- inability or unwillingness to provide informed consent
- rheumatic valve disease (because it results in a unique AF phenotype)
- thrombotic disease or venous filters
- significantly reduced kidney function
Key Trial Info
Start Date :
July 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 11 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04127123
Start Date
July 3 2019
End Date
January 11 2021
Last Update
May 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305